Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

MLA

Charlotte von Engelhardt, et al. “Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial.” JID Innovations, vol. 2, no. 1, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a11faab031b71bf336c5f934900d64dd&authtype=sso&custid=ns315887.

APA

Charlotte von Engelhardt, Christoph Ganss, Martin Gasser, Korinna Kraft, Christiane Pfeiffer, Kathrin Dieter, Matthias Goebeler, Markus Stücker, Samar Sadeghi, Markus H. Frank, Mark A. Kluth, George F. Murphy, Cornelia Erfurt-Berge, Ann-Kathrin Dachtler, Natasha Y. Frank, Dennis P. Orgill, Georg Daeschlein, Andreas Kerstan, Tobias Görge, … Jasmina Esterlechner. (2022). Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial. JID Innovations, 2(1).

Chicago

Charlotte von Engelhardt, Christoph Ganss, Martin Gasser, Korinna Kraft, Christiane Pfeiffer, Kathrin Dieter, Matthias Goebeler, et al. 2022. “Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial.” JID Innovations 2 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a11faab031b71bf336c5f934900d64dd&authtype=sso&custid=ns315887.